{
     "PMID": "26608891",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20161018",
     "LR": "20161230",
     "IS": "1873-474X (Electronic) 0736-5748 (Linking)",
     "VI": "48",
     "DP": "2016 Feb",
     "TI": "Administration of branched-chain amino acids alters the balance between pro-inflammatory and anti-inflammatory cytokines.",
     "PG": "24-30",
     "LID": "10.1016/j.ijdevneu.2015.11.002 [doi] S0736-5748(15)30100-3 [pii]",
     "AB": "Acute leucine intoxication and neurologic deterioration can develop rapidly at any age as a result of net protein degradation precipitated by infection or psychological stress in patients with maple syrup urine disease (MSUD). Here, we investigated the effects of acute and chronic Hyper-BCAA (H-BCAA) administration on pro- and anti-inflammatory cytokines in the brains of rats. For acute administration, Wistar rats (10 and 30 days) received three injections of BCAA pool (15.8 muL/g at 1-h intervals) or saline, subcutaneously. For chronic administration, Wistar rats (7 days) received of BCAA pool or saline twice a day for 21 days, subcutaneously. Our results showed that acute administration of H-BCAA increased IL-1beta ( approximately 78%; p </= 0.009) and TNF-alpha ( approximately 155%; p </= 0.026) levels in the cerebral cortex but not in the hippocampus of infant rats. Moreover, IL-6 levels were increased in the hippocampus ( approximately 135%; p </= 0.009) and cerebral cortex ( approximately 417%; p </= 0.008), whereas IL-10 levels were decreased only in the hippocampus ( approximately 42%; p </= 0.009). However, repeated administration of H-BCAA decreased IL-1beta ( approximately 59%; p </= 0.047), IL-6 ( approximately 70%; p </= 0.009) and IFN-gamma ( approximately 70%; p </= 0.008) levels in the cerebral cortex, whereas the IL-6 ( approximately 67%; p </= 0.009), IL-10 ( approximately 58%; p </= 0.01) and IFN-gamma ( approximately 67%; p </= 0.009) levels were decreased in the hippocampus. These findings suggest that a better understanding of the inflammatory response in MSUD patients may be useful to develop therapeutic strategies to modulate the hyperinflammatory/hypoinflammatory axis.",
     "CI": [
          "Copyright (c) 2015 Elsevier Ltd. All rights reserved."
     ],
     "FAU": [
          "Rosa, Luciana",
          "Scaini, Giselli",
          "Furlanetto, Camila B",
          "Galant, Leticia S",
          "Vuolo, Francieli",
          "Dall'Igna, Dhebora M",
          "Schuck, Patricia F",
          "Ferreira, Gustavo C",
          "Dal-Pizzol, Felipe",
          "Streck, Emilio L"
     ],
     "AU": [
          "Rosa L",
          "Scaini G",
          "Furlanetto CB",
          "Galant LS",
          "Vuolo F",
          "Dall'Igna DM",
          "Schuck PF",
          "Ferreira GC",
          "Dal-Pizzol F",
          "Streck EL"
     ],
     "AD": "Laboratorio de Bioenergetica e Nucleo de Excelencia em Neurociencias Aplicadas de Santa Catarina (NENASC), Programa de Pos-Graduacao em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil; Instituto Nacional de Ciencia e Tecnologia Translacional em Medicina (INCT-TM), Porto Alegre, RS, Brazil. Laboratorio de Bioenergetica e Nucleo de Excelencia em Neurociencias Aplicadas de Santa Catarina (NENASC), Programa de Pos-Graduacao em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil; Instituto Nacional de Ciencia e Tecnologia Translacional em Medicina (INCT-TM), Porto Alegre, RS, Brazil. Laboratorio de Bioenergetica e Nucleo de Excelencia em Neurociencias Aplicadas de Santa Catarina (NENASC), Programa de Pos-Graduacao em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil; Instituto Nacional de Ciencia e Tecnologia Translacional em Medicina (INCT-TM), Porto Alegre, RS, Brazil. Instituto Nacional de Ciencia e Tecnologia Translacional em Medicina (INCT-TM), Porto Alegre, RS, Brazil; Laboratorio de Fisiopatologia Experimental, Programa de Pos-graduacao em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Instituto Nacional de Ciencia e Tecnologia Translacional em Medicina (INCT-TM), Porto Alegre, RS, Brazil; Laboratorio de Fisiopatologia Experimental, Programa de Pos-graduacao em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Instituto Nacional de Ciencia e Tecnologia Translacional em Medicina (INCT-TM), Porto Alegre, RS, Brazil; Laboratorio de Fisiopatologia Experimental, Programa de Pos-graduacao em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Erros Inatos do Metabolismo, Programa de Pos-graduacao em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Erros Inatos do Metabolismo, Programa de Pos-graduacao em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Instituto Nacional de Ciencia e Tecnologia Translacional em Medicina (INCT-TM), Porto Alegre, RS, Brazil; Laboratorio de Fisiopatologia Experimental, Programa de Pos-graduacao em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil. Laboratorio de Bioenergetica e Nucleo de Excelencia em Neurociencias Aplicadas de Santa Catarina (NENASC), Programa de Pos-Graduacao em Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, SC, Brazil; Instituto Nacional de Ciencia e Tecnologia Translacional em Medicina (INCT-TM), Porto Alegre, RS, Brazil. Electronic address: emiliostreck@gmail.com.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20151130",
     "PL": "England",
     "TA": "Int J Dev Neurosci",
     "JT": "International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience",
     "JID": "8401784",
     "RN": [
          "0 (Amino Acids, Branched-Chain)",
          "0 (Cytokines)"
     ],
     "SB": "IM",
     "MH": [
          "Amino Acids, Branched-Chain/*administration & dosage",
          "Animals",
          "Animals, Newborn",
          "Brain/*drug effects/growth & development/metabolism",
          "Cytokines/*metabolism",
          "Drug Administration Schedule",
          "Gene Expression Regulation, Developmental/drug effects",
          "Male",
          "Rats",
          "Rats, Wistar",
          "Time Factors"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Brain",
          "Branched chain amino acids",
          "Cytokines",
          "Maple syrup urine disease"
     ],
     "EDAT": "2015/11/27 06:00",
     "MHDA": "2016/10/19 06:00",
     "CRDT": [
          "2015/11/27 06:00"
     ],
     "PHST": [
          "2015/08/26 00:00 [received]",
          "2015/11/11 00:00 [revised]",
          "2015/11/11 00:00 [accepted]",
          "2015/11/27 06:00 [entrez]",
          "2015/11/27 06:00 [pubmed]",
          "2016/10/19 06:00 [medline]"
     ],
     "AID": [
          "S0736-5748(15)30100-3 [pii]",
          "10.1016/j.ijdevneu.2015.11.002 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Int J Dev Neurosci. 2016 Feb;48:24-30. doi: 10.1016/j.ijdevneu.2015.11.002. Epub 2015 Nov 30.",
     "term": "hippocampus"
}